Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson’s disease

Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control Study

(2019) Ruinan Shen et al.   Frontiers in Neurology

Parkinson’s disease and enhanced inflammatory response

(2015) Iva Stojkovska et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients

(2014) Veselin Grozdanov et al.   ACTA NEUROPATHOLOGICA

MCP-1 and CCR2 gene polymorphisms in Parkinson’s disease in a Han Chinese cohort

(2014) Liang Gao et al.   NEUROLOGICAL SCIENCES

Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases

(2013) Shambhunath Bose et al.   ARCHIVES OF PHARMACAL RESEARCH

Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairment

(2013) Daniel Lindqvist et al.   BRAIN BEHAVIOR AND IMMUNITY

Inflammation in neurodegenerative diseases - an update

(2013) Sandra Amor et al.   IMMUNOLOGY

Etiology and pathogenesis of Parkinson's disease

(2011) Anthony H. Schapira et al.   MOVEMENT DISORDERS

Priorities in Parkinson's disease research

(2011) Wassilios G. Meissner et al.   NATURE REVIEWS DRUG DISCOVERY

The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases

(2010) Grégory Conductier et al.   JOURNAL OF NEUROIMMUNOLOGY

Peripheral cytokines profile in Parkinson’s disease

(2008) M. Reale et al.   BRAIN BEHAVIOR AND IMMUNITY